Capital Expenditures for Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's current capital expenditures (TTM) is $7.84B USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
LLY
Currently viewingCapital ExpendituresSwitch metric
Latest period
$7.84B
YoY change
-6.7%
5Y CAGR
+31.0%
Peak year (2024)
$8.40B
Cumulative capital expenditures
$65.25B
CapEx history chart for Eli Lilly (LLY) from 1989 to 2025
CapEx history table for Eli Lilly (LLY) from 1989 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $7.84B | -6.7% | ||
| 2024 | $8.40B | +13.7% | ||
| 2023 | $7.39B | +147.6% | ||
| 2022 | $2.99B | +50.9% | ||
| 2021 | $1.98B | -2.5% | ||
| 2020 | $2.03B | +49.9% | ||
| 2019 | $1.35B | -55.2% | ||
| 2018 | $3.02B | +39.5% | ||
| 2017 | $2.16B | +98.1% | ||
| 2016 | $1.09B | -32.8% | ||
| 2015 | $1.63B | +3.9% | ||
| 2014 | $1.57B | +43.2% | ||
| 2013 | $1.09B | +4.7% | ||
| 2012 | $1.04B | -38.3% | ||
| 2011 | $1.69B | +42.7% | ||
| 2010 | $1.19B | +38.8% | ||
| 2009 | $855.00M | -9.7% | ||
| 2008 | $947.20M | -12.5% | ||
| 2007 | $1.08B | +0.4% | ||
| 2006 | $1.08B | -17.0% | ||
| 2005 | $1.30B | -31.6% | ||
| 2004 | $1.90B | +11.2% | ||
| 2003 | $1.71B | +50.9% | ||
| 2002 | $1.13B | +27.9% | ||
| 2001 | $884.00M | +30.4% | ||
| 2000 | $677.90M | +28.3% | ||
| 1999 | $528.30M | +25.8% | ||
| 1998 | $419.90M | +14.6% | ||
| 1997 | $366.30M | -17.5% | ||
| 1996 | $443.90M | -19.5% | ||
| 1995 | $551.30M | -4.4% | ||
| 1994 | $576.50M | -9.0% | ||
| 1993 | $633.50M | -36.8% | ||
| 1992 | $1.00B | -12.3% | ||
| 1991 | $1.14B | +13.4% | ||
| 1990 | $1.01B | +81.7% | ||
| 1989 | $554.50M | — |
CapEx values are taken from Eli Lilly's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual capital expenditures for Eli Lilly (LLY) came in at $7.84B – declined 6.7% year-over-year.
Through 2020–2025 (5 years), Eli Lilly capital expenditures delivered a +31.0% annualised rate; with the latest reading among the more recent periods of the dataset.
Eli Lilly capital expenditures declined from $8.40B in 2024 to $7.84B in 2025, a 6.7% drawdown.
2024 marks the peak capital expenditures at $8.40B, with the historical low of $366.30M recorded in 1997.
Eli Lilly (LLY) sits 2nd of 8 Healthcare peers we track on this metric, against a peer median of $3.22B.
Eli Lilly Capital Expenditures by Year
Eli Lilly Capital Expenditures 2025: $7.84B
Eli Lilly capital expenditures in 2025 was $7.84B, declined 6.7% below 2024.
Eli Lilly Capital Expenditures 2024: $8.40B
Eli Lilly capital expenditures in 2024 was $8.40B, grew 13.7% from 2023. This figure represents the highest annual value in the available history.
Eli Lilly Capital Expenditures 2023: $7.39B
Eli Lilly capital expenditures in 2023 was $7.39B, surged 147.6% from 2022.
Eli Lilly Capital Expenditures 2022: $2.99B
Eli Lilly capital expenditures in 2022 was $2.99B, surged 50.9% from 2021.
Eli Lilly Capital Expenditures 2021: $1.98B
Eli Lilly capital expenditures in 2021 was $1.98B.
See more financial history for Eli Lilly (LLY).
Sector peers — CapEx
Companies in the same sector as Eli Lilly, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $1.52B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Eli Lilly's capital expenditures?
- Latest reported capital expenditures for Eli Lilly (LLY) is $7.84B (period ending December 31, 2025).
How has Eli Lilly capital expenditures changed year-over-year?
- Eli Lilly (LLY) capital expenditures changed -6.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Eli Lilly capital expenditures?
- Eli Lilly (LLY) capital expenditures compound annual growth rate is +31.0% over the most recent 5 years available.
When did Eli Lilly capital expenditures hit its highest annual value?
- Eli Lilly capital expenditures reached its highest annual value of $8.40B in 2024.
What was Eli Lilly capital expenditures in 2024?
- Eli Lilly (LLY) capital expenditures in 2024 was $8.40B.
What was Eli Lilly capital expenditures in 2025?
- Eli Lilly (LLY) capital expenditures in 2025 was $7.84B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
LLY Overview
Company profile, financial tools, and key metrics
LLY Revenue Counter
Earns $2,067 every second. See per minute, hour, and day.
LLY Earnings Counter
Earns $654.44 per second net profit. See per minute, hour, and day.
LLY Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
LLY What If Invested
What if you had invested $1,000? See historical returns from any date.
LLY How It Makes Money
Discover visual breakdown of $65.18B in revenue — where it comes from and where it goes.
LLY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LLY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LLY Daily Price Character
Steady · 48.0% historical win rate (green days). Streaks & record days.
LLY Buybacks
0.43% TTM buyback yield. Shareholder yield & SBC comparison.
LLY Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LLY Dividend Profile
Yield: 0.73%. Safety: 8/8. See full history.
LLY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LLY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.